Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Change in Accured Expenses: 2015-2020

Historic Change in Accured Expenses for Outlook Therapeutics (OTLK) over the last 6 years, with Sep 2020 value amounting to $511,157.

  • Outlook Therapeutics' Change in Accured Expenses fell 15.90% to $511,157 in Q3 2020 from the same period last year, while for Sep 2020 it was $726,332, marking a year-over-year increase of 250.48%. This contributed to the annual value of $491,728 for FY2024, which is 169.10% up from last year.
  • According to the latest figures from Q3 2020, Outlook Therapeutics' Change in Accured Expenses is $511,157, which was up 13.85% from $448,981 recorded in Q2 2020.
  • In the past 5 years, Outlook Therapeutics' Change in Accured Expenses ranged from a high of $3.0 million in Q2 2016 and a low of -$2.6 million during Q4 2017.
  • In the last 3 years, Outlook Therapeutics' Change in Accured Expenses had a median value of $448,981 in 2020 and averaged $103,503.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first plummeted by 371.46% in 2016, then skyrocketed by 2,718.06% in 2019.
  • Quarterly analysis of 5 years shows Outlook Therapeutics' Change in Accured Expenses stood at $1.2 million in 2016, then tumbled by 309.79% to -$2.6 million in 2017, then soared by 44.56% to -$1.4 million in 2018, then skyrocketed by 177.89% to $1.1 million in 2019, then declined by 15.90% to $511,157 in 2020.
  • Its Change in Accured Expenses was $511,157 in Q3 2020, compared to $448,981 in Q2 2020 and -$1.3 million in Q1 2020.